Vita Coco Company Inc

PepsiCo reported second-quarter revenues of $24.18 billion, up 6.4% year on year and 0.8% above analysts' expectations, though the stock has fallen 9.8% since the results and trades at $128.50. The results came as the 13 beverages, alcohol, and tobacco stocks tracked by the report delivered a satisfactory quarter overall, with group revenues beating consensus estimates by 1% and next-quarter revenue guidance coming in 2.2% above expectations, even as share prices across the group fell an average of 10.4% since the latest earnings results. Vita Coco posted the group's best quarter, with revenues of $216.2 million, up 28.1% year on year and 3% ahead of estimates, alongside beats on EPS and gross margin estimates and the highest full-year guidance raise in the group, though its stock is down 21.1% since reporting and trades at $58.77. Celsius turned in the weakest quarter, with revenues of $817.9 million, up 10.6% year on year but 6.2% short of analysts' expectations, marked by significant misses on EBITDA and EPS estimates; its stock is down 4% since the results and trades at $27.99. Among other peers, Molson Coors reported revenues of $3.10 billion, down 3.3% year on year and in line with expectations, with its stock down 13.9% at $36.05, while Altria reported revenues of $5.36 billion, up 1.2% year on year and in line with expectations, with its stock down 8.3% at $68.69.

Philip Morris International reported second-quarter revenues of $11.19 billion, up 10.4% year on year and 5.5% above analysts' consensus estimates, the biggest estimate beat among the 13 beverages, alcohol, and tobacco stocks tracked. Vita Coco posted the group's best quarter, with revenues of $216.2 million, up 28.1% year on year and 3% ahead of expectations, and the highest full-year guidance raise among its peers, though its stock is down 22.7% since reporting and trades at $57.55. Celsius delivered the weakest performance against estimates, with revenues of $817.9 million, up 10.6% year on year but 6.2% short of expectations, missing significantly on EBITDA and EPS, and its stock is down 2.3% at $28.48. Zevia reported revenues of $45 million, up 1.1% year on year and 1.8% above expectations, while Boston Beer's revenues of $568.3 million fell 3.3% year on year and were in line with expectations. As a group, the 13 stocks beat consensus revenue estimates by 1% and guided next-quarter revenue 2.2% above, yet their shares are down an average of 7.1% since the latest results.

Vita Coco has acquired Copra, a producer of super-premium Thai Nam Hom coconut water, in a $175 million deal that includes a factory in Thailand and an extract-and-fill-on-site model. Copra grew net sales at a 48% compound annual rate over three years and should clear $100 million this year, and the deal's earnout has a floor of $45 million and a cap of $100 million based on 2028 results. Vita Coco paid roughly 1.75 times what Copra expects to bring in this year, with the upfront price near seven times profits based on about $25 million in EBITDA. The stock is down roughly 40% from its June peaks, and insiders sold about 343,900 shares worth roughly $27.4 million, including a $1.25 million sale by Chief Executive Martin Roper in April, though no insider has sold since the Copra deal closed. Management expects full-year gross margin to settle closer to 40% as tariff refunds and freight savings fade.

MGP Ingredients reported second-quarter revenues of $124.4 million, down 14.5% year on year and 0.7% below analyst expectations, though it beat EPS and EBITDA estimates. Among the 13 beverages, alcohol, and tobacco stocks tracked, the group overall beat revenue consensus by 1% and guided next quarter 2.2% above. Vita Coco was the best performer with revenue up 28.1% to $216.2 million, while Celsius was the weakest, missing revenue estimates by 6.2% despite 10.6% growth to $817.9 million. Molson Coors revenue fell 3.3% to $3.10 billion, meeting expectations, and Zevia revenue rose 1.1% to $45 million, beating by 1.8%.

The beverages, alcohol, and tobacco sector reported a mixed second quarter, with aggregate revenues beating analyst consensus by 1% while next-quarter revenue guidance came in 2.2% above expectations. Altria posted revenue of $5.36 billion, up 1.2% year-on-year and in line with estimates, but its stock fell 8.9% since the report. Vita Coco delivered the best performance of the group, with revenue of $216.2 million, a 28.1% increase that exceeded expectations by 3%, and it raised full-year guidance, though shares still dropped 16.4%. Celsius was the weakest, missing revenue estimates by 6.2% with $817.9 million, a 10.6% rise, and its stock declined 5.8%. Constellation Brands beat revenue expectations by 1.6% with $2.43 billion, down 3.3% year-on-year, but issued the weakest full-year guidance update among peers, and its shares slipped 2.4%. PepsiCo surpassed revenue estimates by 0.8% with $24.18 billion, up 6.4%, yet its stock fell 2.3%.

Zacks Investment Research identifies five soft drink stocks poised for growth amid rising demand for healthier beverages and digital transformation. The Zacks Beverages – Soft Drinks industry, ranked in the top 37% of over 250 Zacks industries, is benefiting from consumer shifts toward zero-sugar, low-calorie, and functional drinks, as well as investments in AI, e-commerce, and smart manufacturing. The Coca-Cola Company, Monster Beverage Corporation, Fomento Económico Mexicano, Primo Brands Corporation, and The Vita Coco Company are highlighted as well-positioned to capitalize on these trends, though the industry faces headwinds from rising input costs and tariff uncertainty. Vita Coco holds a Zacks Rank #1, Coca-Cola and Primo Brands hold a Zacks Rank #2, and Monster Beverage and Fomento Económico Mexicano hold a Zacks Rank #3.

Zacks Investment Research recommends four consumer staples stocks as a defensive play amid declining consumer confidence and market volatility. Consumer confidence fell to 90.8 in July from an upwardly revised 92.2 a month earlier, according to the Conference Board, missing the consensus estimate of 92.3. The Present Situation Index declined 3.6 points to 114.9, marking its third straight monthly drop, while the Expectations Index held at 74.7. The recommended stocks are The Vita Coco Company, The Coca-Cola Company, John Wiley & Sons, and Carriage Services, all of which have seen positive earnings estimate revisions over the past 90 days.

The Vita Coco Company has acquired fellow coconut waters firm Copra for an initial purchase price of $175 million, paid up-front upon closing, with an additional earnout consideration of $45 million to $100 million payable in 2029 based on Copra's 2028 financial results. Copra, based in New York with production in Thailand, is described as one of the leading producers of super-premium Thai Nam Hom coconut water and also markets coconut food products. Vita Coco expects the acquisition to be accretive to its adjusted EBITDA margins following full integration, citing Copra's nearly 50% net sales compound annual growth rate over the past three years in the cold-chain coconut water segment. Copra anticipates annual net sales will exceed $100 million this year, mostly in the Americas, with opportunities to expand internationally and grow its branded business. Vita Coco plans to expand capacity, invest behind the brand, and improve operational efficiency to capture more consumers and market share in the fast-growing coconut water category.

U.S. stock futures pointed lower on Thursday amid a deluge of earnings reports and rising oil prices. Vita Coco surged 8.8% after second-quarter net sales rose 28% to $216 million and adjusted EBITDA reached $67 million, well above estimates. Domo soared 21% on news that Progress Software will acquire substantially all of its assets for $400 million in cash. Mobileye fell 4.4% as founder and CEO Amnon Shashua announced plans to step down, overshadowing an earnings beat. Dow Inc. slipped 2.8% despite adjusted earnings per share of $1.44 topping forecasts, while Hut 8 gained 6.0% after Morgan Stanley initiated coverage with an Overweight rating and a $263 price target.

The Vita Coco Company reported second-quarter revenue of $216.2 million, beating analyst estimates of $209.9 million and growing 28.1% year on year. GAAP earnings per share came in at $0.82, 47.3% above the consensus estimate of $0.56, while adjusted EBITDA of $67.23 million exceeded expectations by 49.1%. The company raised its full-year revenue guidance to $797.5 million at the midpoint, up from $727.5 million and 8% above analyst forecasts, and set EBITDA guidance at $157.5 million, above the $140.8 million consensus. Operating margin expanded to 29.2% from 14.9% a year ago, and free cash flow margin reached 37.4%, up from 12.4% in the same quarter last year.

Vita Coco shares have rallied 43.2% year-to-date and nearly doubled over the past 12 months, pushing its valuation to 39.52 times forward earnings, more than double the 19.05 times for its Zacks sub-industry. First-quarter net sales rose 37.3% to $179.8 million, earnings per share climbed to 50 cents from 31 cents, and management raised its full-year net sales guidance to $720 million to $735 million with adjusted EBITDA of $132 million to $138 million. The company ended the quarter with $202 million in cash and no debt, and repurchased $12 million of shares. However, management cautioned that first-quarter growth was boosted by promotional timing with a major club retailer and that second-half margins may face pressure from higher packaging, energy, transportation, and promotional costs. The stock carries a Zacks Rank of 2, or Buy, but its Value Score of F and VGM Score of D suggest bargain-focused investors may want a better entry point.

Vita Coco's stock outlook hinges on branded demand, international expansion and margin execution. The company held more than 40% U.S. market share and about 80% U.K. share as of late 2025, with coconut water representing 96% of its 2025 sales. First-quarter 2026 net sales rose 37.3% to $180 million, gross margin expanded 320 basis points to 39.9%, and net income reached $30 million. International segment net sales surged 72%, driven by Europe, though management cautioned that the quarter benefited from a club promotion timing shift and should not be annualized. Cost pressures from finished goods, packaging, energy, tariffs and promotions could limit margin gains later in the year.

Vita Coco has emerged as the more promising investment over Coca-Cola, driven by stronger growth momentum and upward earnings revisions. Shares of Vita Coco have surged 54.7% in the past three months, far outpacing Coca-Cola's 8.9% gain. Vita Coco's 2026 revenues and earnings per share are projected to increase 22.3% and 48.7% year over year, respectively, while Coca-Cola's are expected to rise 3% and 8.7%. Vita Coco carries a Zacks Rank of 2, or Buy, compared with Coca-Cola's Zacks Rank of 3, or Hold. Although Vita Coco trades at a higher forward price-to-earnings multiple of 39.02 times versus Coca-Cola's 24.37 times, its expanding coconut water leadership and improving analyst confidence support greater upside potential.

Vita Coco Company has been identified as a strong growth stock by Zacks Investment Research, earning a Growth Score of B and a Zacks Rank #2. The company's earnings per share are projected to grow 48.7% this year, far outpacing the industry average of 13.6%. Year-over-year cash flow growth stands at 12.4%, compared to the industry average of 4.8%, while annualized cash flow growth over the past three to five years is 15.8% versus the industry's 12%. Positive earnings estimate revisions have also lifted the Zacks Consensus Estimate for the current year by 0.4% over the past month.

Vita Coco Company is back in focus after analysts turned more positive, pointing to earnings estimate revisions and sales growth running well ahead of Consumer Staples sector averages. The stock last closed at $71.40, against a most-followed fair value estimate of $75.11 that applies a 7.11% discount rate to its future cash flows, suggesting it is 4.9% undervalued. Heightened investment in international markets, notably Europe, is resulting in accelerating sales growth and market share gains, with management expecting international revenues to ultimately rival the Americas business. However, the narrative still faces pressure points, including potential tariff increases on coconut imports and ongoing freight cost volatility that could squeeze margins. The current P/E of 49.2x compares with 16.7x for the global Beverage industry and a fair ratio of 22x, pointing to meaningful valuation risk if sentiment cools.

Piper Sandler has raised its price target on The Vita Coco Company following a reported 32.7% sales increase through mid-June, excluding club channels. The company is set to release its second-quarter 2026 results on July 23 and will host a conference call to discuss performance across its coconut water and broader better-for-you beverage portfolio. Analyst commentary has emphasized strong recent sales trends and a more optimistic earnings outlook, building expectations ahead of the upcoming results. The bullish sentiment centers on whether Vita Coco can sustain category growth while managing input costs and private label volatility, though the announcement itself does not materially change the biggest current risk from tariffs and freight costs.

The 13 beverages, alcohol, and tobacco stocks tracked reported a strong Q1, with revenues beating analysts' consensus estimates by 4.9% on average, though next quarter's revenue guidance came in 3% below. Celsius led the group with revenue growth of 138% year on year to $782.6 million, exceeding expectations by 2.6%, but its stock fell 10.7% as investor hopes ran higher. Vita Coco delivered the biggest analyst estimate beat, with revenue up 37.3% to $179.8 million, topping forecasts by 20.5%, and its stock surged 28.3%. Boston Beer was the weakest performer, with revenue down 4.4% to $433.9 million and a significant miss on adjusted operating income and EPS, sending its stock down 22%. Constellation Brands reported revenue of $2.43 billion, down 3.3% but beating estimates by 1.6%, while PepsiCo posted revenue of $19.44 billion, up 8.5% and surpassing expectations by 2.9%.

Brown-Forman reported third-quarter revenue of $1.04 billion, a 5.4% decline from a year earlier, beating analyst estimates by 1.7% but missing EBITDA expectations. The 14 beverages, alcohol, and tobacco stocks tracked by StockStory collectively beat revenue consensus by 4.7%, though next-quarter guidance came in 3% below estimates. Vita Coco was the standout performer with revenue surging 37.3% to $179.8 million, exceeding forecasts by 20.5%, while Boston Beer lagged with a 4.4% revenue drop to $433.9 million and significant misses on operating income and EPS. Altria posted a 5.3% revenue gain to $4.76 billion, and Monster Beverage grew 26.9% to $2.35 billion, both topping analyst expectations.

Vita Coco Company and Darling Ingredients have each returned more than 47% year-to-date, far exceeding the Consumer Staples sector's average gain of 5.6%. Vita Coco has returned about 56.4% since the start of the year, while Darling Ingredients has returned 47.8%. Both stocks carry a Zacks Rank of 1, or Strong Buy, and have seen their full-year consensus earnings estimates revised sharply higher over the past 90 days—up 11.4% for Vita Coco and 40.3% for Darling Ingredients. Within their respective industries, Vita Coco's beverages-soft drinks group has gained an average of 10.8% this year, and Darling Ingredients' food-miscellaneous industry has declined 6.7%, highlighting the stocks' standout performance.

Zacks Investment Research recommends five health and fitness stocks that delivered strong first-half returns and carry favorable Zacks Ranks, signaling further upside. Columbia Sportswear, a Zacks Rank #1, is advancing its ACCELERATE strategy targeting younger consumers and has seen its current-year earnings estimate rise 3.8% over the last 30 days. OneSpaWorld Holdings, a Zacks Rank #2 provider of wellness services on cruise ships and on land, has a current-year earnings growth estimate of 17.2% and a 3.6% upward revision in the past 60 days. United Natural Foods, also a Zacks Rank #2, is benefiting from efficiency initiatives and private-brand innovation, with next-year earnings estimates up 10.9% over the last 30 days. Vita Coco, a Zacks Rank #1, is projected to grow earnings 47.9% this year and has seen estimates climb 11.4% over 60 days. Life Time Group, a Zacks Rank #2 operator of health and fitness communities, has a current-year earnings growth estimate of 16% and a 5% positive revision over 60 days.

StockStory highlights Vita Coco as a Russell 2000 stock with exciting potential while advising caution on Varonis Systems and ePlus. Vita Coco, with a market cap of $4.49 billion, saw unit sales surge over the past two years and delivered annual EPS growth of 52.4% over three years, with rising returns on capital. Varonis Systems, valued at $3.84 billion, faces risks from below-standard revenue growth, high marketing costs, and a 2.5 percentage point drop in operating margin. ePlus, at a $2.17 billion market cap, showed muted 4.8% annual revenue growth, lagging EPS gains, and a 2.5 percentage point decline in free cash flow margin over five years.

Monster Beverage reported first-quarter revenues of $2.35 billion, a 26.9% increase year on year and 9.3% above analyst expectations, marking the first time quarterly net sales crossed the $2 billion threshold. The company also posted a solid beat on EBITDA estimates, with operating income up 28.1% and diluted earnings per share rising 27.6%. Among the 13 beverages, alcohol, and tobacco stocks tracked, the group overall beat revenue consensus by 4.9% but guided next-quarter revenue 3% below estimates. Vita Coco delivered the biggest analyst estimate beat with revenues of $179.8 million, up 37.3% year on year, while Boston Beer was the weakest performer, with revenues down 4.4% to $433.9 million and a significant miss on adjusted operating income and EPS. Monster shares have risen 20.4% since the report.